These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16938710)

  • 1. Infliximab in ulcerative colitis.
    Böcker U
    Scand J Gastroenterol; 2006 Sep; 41(9):997-1000. PubMed ID: 16938710
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour necrosis factor alpha downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula.
    Hassan C; Zullo A; Ierardi E; Burattini O; De Francesco V; Morini S
    Gut; 2006 Apr; 55(4):589-90. PubMed ID: 16531548
    [No Abstract]   [Full Text] [Related]  

  • 3. Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis.
    Arijs I; Li K; Toedter G; Quintens R; Van Lommel L; Van Steen K; Leemans P; De Hertogh G; Lemaire K; Ferrante M; Schnitzler F; Thorrez L; Ma K; Song XY; Marano C; Van Assche G; Vermeire S; Geboes K; Schuit F; Baribaud F; Rutgeerts P
    Gut; 2009 Dec; 58(12):1612-9. PubMed ID: 19700435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab in ulcerative colitis.
    Aberra FN; Lichtenstein GR
    Gastroenterol Clin North Am; 2006 Dec; 35(4):821-36. PubMed ID: 17129815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural evidence of mucosal healing after infliximab in patients with ulcerative colitis.
    Fratila OC; Craciun C
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):147-53. PubMed ID: 20593047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor necrosis factor therapy for ulcerative colitis.
    Kountouras J; Zavos C; Chatzopoulos D
    Gastroenterology; 2005 Sep; 129(3):1138-9. PubMed ID: 16143158
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of the anti-tumour necrosis factor monoclonal antibody--infliximab--to treat ulcerative colitis: implications and trends beyond the available data.
    Rossetti S; Actis GC; Fadda M; Rizzetto M; Palmo A
    Dig Liver Dis; 2004 Jun; 36(6):426-31. PubMed ID: 15248385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab for ulcerative colitis following liver transplantation.
    Lal S; Steinhart AH
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):277-80. PubMed ID: 17301656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab for ulcerative colitis.
    Simmons J; Jewell DP
    Dig Liver Dis; 2002 Sep; 34(9):616-8. PubMed ID: 12405245
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study.
    Gustavsson A; Järnerot G; Hertervig E; Friis-Liby I; Blomquist L; Karlén P; Grännö C; Vilien M; Ström M; Verbaan H; Hellström PM; Magnuson A; Halfvarson J; Tysk C
    Aliment Pharmacol Ther; 2010 Oct; 32(8):984-9. PubMed ID: 20937043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab.
    Hassan C; Ierardi E; Burattini O; De Francesco V; Zullo A; Stoppino G; Panella C; Morini S
    Dig Liver Dis; 2007 Sep; 39(9):811-7. PubMed ID: 17652038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of manic switch by the tumour necrosis factor-alpha antagonist infliximab.
    Elisa B; Beny L
    Psychiatry Clin Neurosci; 2010 Aug; 64(4):442-3. PubMed ID: 20653912
    [No Abstract]   [Full Text] [Related]  

  • 14. Infliximab avoiding colectomy and maintaining remission in pediatric immunosuppressive-naïve ulcerative colitis achieving remarkable mucosal healing.
    Sciaudone G; Pellino G; Guadagni I; Selvaggi F
    Panminerva Med; 2010 Mar; 52(1):91-2. PubMed ID: 20228729
    [No Abstract]   [Full Text] [Related]  

  • 15. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
    Jakobovits SL; Jewell DP; Travis SP
    Aliment Pharmacol Ther; 2007 May; 25(9):1055-60. PubMed ID: 17439506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis].
    Mocciaro F; Orlando A; Scimeca D; Cottone M
    Recenti Prog Med; 2007 Nov; 98(11):560-4. PubMed ID: 18044405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of infliximab in patients suffering from inflammatory bowel disease.
    Felley C; Michetti P
    Digestion; 2004; 70(1):1-2. PubMed ID: 15297772
    [No Abstract]   [Full Text] [Related]  

  • 18. Infliximab for refractory ulcerative proctitis.
    Bouguen G; Roblin X; Bourreille A; Feier L; Filippi J; Nancey S; Bretagne JF; Flourié B; Hébuterne X; Bigard MA; Siproudhis L; Peyrin-Biroulet L
    Aliment Pharmacol Ther; 2010 Jun; 31(11):1178-85. PubMed ID: 20222911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab or cyclosporine for severe ulcerative colitis.
    Hanauer SB
    Gastroenterology; 2005 Oct; 129(4):1358-9; author reply 1359. PubMed ID: 16230092
    [No Abstract]   [Full Text] [Related]  

  • 20. Infliximab in refractory severe ulcerative colitis: a case report.
    Bossa F; Caserta L; Selvaggi F; Riegler G
    Minerva Gastroenterol Dietol; 2005 Sep; 51(3):261-2. PubMed ID: 16280968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.